Jason Stout
Overview
Explore the profile of Jason Stout including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
60
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Monardo R, Arif S, Rege A, Simon E, Ledbetter L, Baker A, et al.
Syst Rev
. 2025 Jan;
14(1):21.
PMID: 39844308
Background: Although intravesical Bacillus Calmette-Guerin (BCG) immunotherapy usually exhibits a favorable safety profile, it can lead to the development of BCG infections, both localized and disseminated. Understanding of BCG infections...
2.
Seidelman J, Lewis S, Advani S, Akinboyo I, Epling C, Case M, et al.
Infect Control Hosp Epidemiol
. 2020 Jun;
41(12):1466-1467.
PMID: 32576336
No abstract available.
3.
Rinsky J, Farmer D, Dixon J, Maillard J, Young T, Stout J, et al.
MMWR Morb Mortal Wkly Rep
. 2018 Jun;
67(23):670-671.
PMID: 29902167
No abstract available.
4.
Connelly S, Trinh J, Johnson M, Dodds-Ashley E, Stout J, Engemann J, et al.
Am J Infect Control
. 2008 Oct;
37(2):143-9.
PMID: 18834753
Background: This study examined predictors of in-hospital mortality and time to extubation among patients with acute, severe hospital-acquired pneumonia (HAP) managed in the intensive care unit (ICU). Methods: Patients with...
5.
Hamilton C, Sterling T, Blumberg H, Leonard M, McAuley J, Schlossberg D, et al.
Clin Infect Dis
. 2007 Jun;
45(3):338-42.
PMID: 17599311
Tuberculosis (TB) is an enormous global public health problem. Cases of extensively drug-resistant TB (XDR-TB) are being reported in increasing numbers across the globe. A large outbreak of XDR-TB associated...
6.
Hickey A, Lu D, Ashley E, Stout J
J Aerosol Med
. 2006 Mar;
19(1):54-60.
PMID: 16551215
The treatment of pulmonary infectious diseases with pharmaceutical aerosols is an attractive option considering the accessibility of the lungs for topical drug delivery. Aerosols have been targeted to the lungs...